​

Forte Biosciences (FBRX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

FBRX Stock Forecast

Forte Biosciences (FBRX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $77.00, with a high of $77.00 and a low of $77.00. This represents a 0.27% increase from the last price of $76.79.

- $16 $32 $48 $64 $80 High: $77 Avg: $77 Low: $77 Last Closed Price: $76.79

FBRX Stock Rating

Forte Biosciences stock's rating consensus is Hold, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (42.86%), 4 Hold (57.14%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 7 0 4 3 Strong Sell Sell Hold Buy Strong Buy

FBRX Price Target Upside V Benchmarks

TypeNameUpside
StockForte Biosciences0.27%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts334
Avg Price Target$76.00$76.00$73.25
Last Closing Price$76.79$76.79$76.79
Upside/Downside-1.03%-1.03%-4.61%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 26-14--5
Jul, 26-5---5
Jun, 26-5---5
May, 26-5---5
Apr, 26-5---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 28, 2026Etzer DaroutBarclays$77.00$76.500.65%0.27%
Jul 27, 2026Evercore ISI$77.00$76.420.76%0.27%
Jul 21, 2026Barclays$74.00$47.4955.82%-3.63%
Nov 25, 2025Evercore ISI$65.00$19.06241.03%-15.35%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 28, 2026BarclaysOverweightPositivedowngrade
Jul 27, 2026Cowen & Co.Holddowngrade
Jul 21, 2026BarclaysOverweightinitialise
Nov 25, 2025Evercore ISIOutperforminitialise
Aug 18, 2025GuggenheimBuyinitialise
Jun 18, 2024Rodman & RenshawBuyinitialise
May 29, 2024Brookline CapitalBuyinitialise

Financial Forecast

EPS Forecast

$-40 $-32 $-24 $-16 $-8 $0 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-38.85$-24.92$-12.17$-4.71---
Avg Forecast$-34.75$-14.50$-9.44$-3.68$-2.77$-2.71$-2.26
High Forecast$-34.75$-14.50$-5.24$-3.44$-2.77$-2.71$-2.26
Low Forecast$-34.75$-14.50$-15.48$-4.03$-2.77$-2.71$-2.26
Surprise %11.80%71.86%28.92%27.99%---

Revenue Forecast

$5M $9M $13M $17M $21M $25M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-------
Avg Forecast$9.59K---$9.00M$22.50M$21.12M
High Forecast$11.51K---$9.00M$22.50M$21.12M
Low Forecast$7.67K---$9.00M$22.50M$21.12M
Surprise %-------

Net Income Forecast

$-70M $-56M $-42M $-28M $-14M $0 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-21.71M$-31.48M$-35.48M$-69.38M---
Avg Forecast$-27.03M$-18.31M$-13.08M$-4.72M$-3.49M$-3.42M$-2.85M
High Forecast$-21.63M$-18.31M$-6.62M$-4.35M$-3.49M$-3.42M$-2.85M
Low Forecast$-32.44M$-18.31M$-19.55M$-5.09M$-3.49M$-3.42M$-2.85M
Surprise %-19.69%71.89%171.14%1369.50%---

FBRX Forecast FAQ

Is Forte Biosciences stock a buy?

Forte Biosciences stock has a consensus rating of Hold, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Forte Biosciences is a neutral investment for most analysts.

What is Forte Biosciences's price target?

Forte Biosciences's price target, set by 7 Wall Street analysts, averages $77 over the next 12 months. The price target range spans from $77 at the low end to $77 at the high end, suggesting a potential 0.27% change from the previous closing price of $76.79.

How does Forte Biosciences stock forecast compare to its benchmarks?

Forte Biosciences's stock forecast shows a 0.27% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Forte Biosciences over the past three months?

  • August 2026: 0% Strong Buy, 20.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Forte Biosciences’s EPS forecast?

Forte Biosciences's average annual EPS forecast for its fiscal year ending in December 2026 is $-2.77, marking a -41.19% decrease from the reported $-4.71 in 2025. Estimates for the following years are $-2.71 in 2027, and $-2.26 in 2028.

What is Forte Biosciences’s revenue forecast?

Forte Biosciences's average annual revenue forecast for its fiscal year ending in December 2026 is $9M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $22.5M, and $21.12M for 2028.

What is Forte Biosciences’s net income forecast?

Forte Biosciences's net income forecast for the fiscal year ending in December 2026 stands at $-3.492M, representing a -94.97% decrease from the reported $-69.375M in 2025. Projections indicate $-3.422M in 2027, and $-2.848M in 2028.